Valuation GSK plc

Stocks

Market Closed - London S.E. Other stock markets 11:35:01 2026-08-10 EDT			5-day change	1st Jan Change
1,927.50 ^GBX	-1.68%		+0.94%	+5.65%

08-10	WINNERS & LOSERS: Threat to Vistry; Plus500 plans more share buybacks	AN
08-06	LifeMine Therapeutics, Inc. announced that it has received $188 million in funding from a group of investors	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	80,458	58,381	59,112	54,944	73,201	77,235	-	-
Change	-	-27.44%	1.25%	-7.05%	33.23%	5.51%	-	-
Enterprise Value (EV) ¹	100,296	75,578	74,152	68,039	87,654	96,288	93,324	90,231
Change	-	-24.65%	-1.89%	-8.24%	28.83%	9.85%	-3.08%	-3.31%
P/E	18.6x	3.93x	11.9x	21.3x	12.9x	13.8x	11.7x	10.9x
PBR	5.34x	5.47x	4.4x	4.02x	-	4.64x	4.02x	3.51x
PEG	-	0x	-0.2x	-0.4x	0x	-13.02x	0.7x	1.46x
Capitalization / Revenue	2.36x	1.99x	1.95x	1.75x	2.24x	2.28x	2.17x	2.1x
EV / Revenue	2.94x	2.58x	2.45x	2.17x	2.68x	2.84x	2.62x	2.45x
EV / EBITDA	8.85x	7.23x	6.37x	6.36x	7.77x	8.27x	7.55x	7.03x
EV / EBIT	11.4x	9.27x	8.44x	7.44x	8.96x	9.36x	8.4x	7.77x
EV / FCF	22.6x	12.1x	13.6x	13x	13.7x	17.3x	16.1x	13.3x
FCF Yield	4.42%	8.28%	7.36%	7.67%	7.32%	5.76%	6.21%	7.53%
Dividend per Share ²	1	0.6125	0.58	0.61	0.66	0.6958	0.7495	0.7831
Rate of return	4.98%	4.26%	4%	4.53%	3.62%	3.61%	3.89%	4.06%
EPS ²	1.082	3.662	1.216	0.632	1.411	1.396	1.642	1.765
Distribution rate	92.4%	16.7%	47.7%	96.5%	46.8%	49.8%	45.7%	44.4%
Net sales ¹	34,114	29,324	30,328	31,376	32,667	33,942	35,612	36,785
EBITDA ¹	11,330	10,449	11,635	10,693	11,278	11,650	12,359	12,830
EBIT ¹	8,806	8,151	8,786	9,148	9,783	10,288	11,109	11,613
Net income ¹	4,385	14,956	4,928	2,575	5,716	5,777	6,596	7,090
Net Debt ¹	19,838	17,197	15,040	13,095	14,453	19,053	16,089	12,996
Reference price ²	20.08	14.38	14.50	13.46	18.24	19.28	19.28	19.28
Nbr of stocks (in thousands)	4,006,383	4,060,999	4,076,145	4,080,519	4,012,126	4,007,011	-	-
Announcement Date	2/9/22	2/1/23	1/31/24	2/5/25	2/4/26	-	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GSK PLC	13.57x	2.84x	8.29x	3.55%	106B
ELI LILLY AND COMPANY	33.6x	12.3x	24.81x	0.58%	1,057B
JOHNSON & JOHNSON	28.84x	-	-	2.07%	625B
ABBVIE INC.	32.43x	7.35x	15.3x	2.81%	435B
ROCHE HOLDING AG	20.47x	4.85x	12.02x	2.72%	363B
NOVARTIS AG	22.14x	5.72x	14.28x	2.8%	296B
ASTRAZENECA PLC	20.58x	4.25x	12.07x	2.07%	249B
AMGEN INC.	25.76x	6.78x	12.06x	2.45%	222B
NOVO NORDISK A/S	13.84x	4.97x	10.44x	3.68%	209B
GILEAD SCIENCES, INC.	-41.37x	5.93x	33.46x	2.47%	165B
Average	16.99x	6.11x	15.86x	2.52%	372.68B
Weighted average by Cap.	24.14x	7.91x	17.97x	2.03%